We are a global biopharmaceutical company focused on helping to address the unmet medical needs of patients with serious diseases. We are investing billions in Research and Development (R&D), which includes the discovery and development of new medicines.
Below is a list of our company's marketed products available in Canada. Any linked documents and websites are intended only for residents of Canada 18 years or older.
If you are not a resident of Canada, please refer to the full prescribing information approved by the relevant governmental authority of the country where you are located and consult your physician for professional medical advice and services.
ATRIPLA® (efavirenz/emtricitabine/ tenofovir disoproxil fumarate)
ENDOCET® (oxycodone hydrochloride 5 mg and acetaminophen 325 mg)
EVOTAZ® (atazanavir and cobicistat tablets)
FUNGIZONE® (amphotericin B)
HYCODAN® (hydrocodone bitartrate)
KENALOG-10® Injection (triamcinolone)
KENALOG-40® Injection (triamcinolone)
MEGACE® OS (megestrol)
MODECATE® CONCENTRATE (fluphenazine)
PERCOCET® (oxycodone hydrochloride 5 mg / acetaminophen 325 mg)
PERCOCET®-DEMI (oxycodone hydrochloride 2.5 mg / acetaminophen 325 mg)
SUSTIVA® (efavirenz, USP)
VIDEX EC® (didanosine)